Nigeria Cold Flu Supplements Market Size & Outlook, 2026-2034
Last Updated : 10 September, 2026 |
Study Period : 2022-2034 |
Format : PDF, Excel |
Author : Anna Morgan
Nigeria Cold Flu Supplements Market Insights
- Based on Deep Market Insights findings, the Nigeria Cold Flu Supplements Market reached USD 16.97 Million in 2025 and is estimated to attain USD 28.28 Million by 2034.
- From 2026 to 2034, the Nigeria market is expected to grow at a steady CAGR of 5.84%.
- Within the By Product Type category, Cold Relief Supplements dominated in 2025 in terms of market size contribution.
- Over the forecast period, Immune Support Supplements is forecasted to deliver the fastest growth, positioning it as the most lucrative By Product Type segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, Nigeria held 0.44% of the global Cold Flu Supplements Market size.
- By 2034, United States is anticipated to capture the largest share of the global Cold Flu Supplements Market.
- In Middle East and Africa, United Arab Emirates is expected to lead the regional Cold Flu Supplements Market size by 2034.
- United Arab Emirates will remain the fastest-growing market in Middle East and Africa, reaching USD 371.21 Million by 2034.
Nigeria Cold Flu Supplements Market By Product Type 2026-2034 (USD Million)
| By Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cold Relief Supplements | XX.x | XX.x | XX.x | 7.66 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Flu Relief Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Immune Support Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Combination Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 16.97 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Nigeria Cold Flu Supplements Market By Form 2026-2034 (USD Million)
| By Form | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets and Capsules | XX.x | XX.x | XX.x | 6.79 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gummies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Liquid and Syrups | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 16.97 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Nigeria Cold Flu Supplements Market By Ingredient 2026-2034 (USD Million)
| By Ingredient | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitamins and Minerals | XX.x | XX.x | XX.x | 6.91 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Herbal Extracts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Probiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Functional Ingredients | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 16.97 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Nigeria Cold Flu Supplements Market By Distribution Channel 2026-2034 (USD Million)
| By Distribution Channel | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacies and Drugstores | XX.x | XX.x | XX.x | 7.69 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supermarkets and Hypermarkets | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Online Retail | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Stores | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 16.97 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 16.97 Million |
| Market Size In 2034 | USD 28.28 Million |
| Largest segment | Cold Relief Supplements |
| Units | Revenue in USD Million |
| CAGR | 5.84% (2026-2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |